NCT Number: NCT05113537
Phase: PHASE1|PHASE2
Trial Summary: This phase I/II trial tests the safety, side effects, and best dose of abemaciclib and whether it works before 177Lu-PSMA-617 in treating patients with castration resistant prostate cancer that has sp – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Vadim S Koshkin
Acronym: UPLIFT
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives